Latest updates for Bone Biologics

Fresh curated links around bone biologics are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bone Biologics Bets on a More Selective Path to Spine Fusion
  • Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
  • Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

orthotw.com /1 month ago

Bone Biologics Bets on a More Selective Path to Spine Fusion

For most of the past two decades, the orthobiologics shelf has been defined by a familiar tradeoff.

Read source
orthotw.com /1 month ago

Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone

Read source
orthospinenews.com /1 month ago

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2…

Read source
orthospinenews.com /1 day ago

Bone Biologics Expands Trial Sites

Addition of three sites strengthens expectation to complete enrollment by year-end 2026 BURLINGTON, MA, Sept. 08, 2026 (GLOBE…

Read source
orthospinenews.com /1 month ago

Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone

HOPKINTON, MA – August 5, 2026 – Isto Biologics (“Isto”), a biologics company dedicated to advancing bone healing,…

Read source
newswire.com /1 month ago

Isto Biologics Strengthens its Bone Graft Substitutes Platform with the Acquisition of NovaBone

Isto Biologics has acquired NovaBone Products from Halma plc, expanding its synthetic bone graft portfolio and global reach in orthopedic and dental markets.

Read source
orthospinenews.com /3 weeks ago

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

NEWS PROVIDED BY FibroBiologics, Inc.  Aug 18, 2026, 08:30 ET Animal trials show cartilage repair within four weeks…

Read source
orthotw.com /3 weeks ago

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

Animal trials show cartilage repair within four weeks following a single injection of chondrocyte spheroids

Read source
bioengineer.org /3 weeks ago

Coral-inspired scaffold reprograms immune cells to accelerate bone regeneration

A coral-inspired scaffold that combines multi-walled carbon nanotubes with nano-hydroxyapatite has shown promise in restoring bone regeneration in steroid-induced osteonecrosis of...

Read source
orthotw.com /1 week ago

Anabolic Bone Therapy Cuts Junctional Failure Risk 49%

Can spine surgeons cut the risk of proximal junctional kyphosis in half by attending to bone quality pre-operatively?

Read source
genengnews.com /1 month ago

Genetic Map Opens Door to Development of New Therapies to Reverse Bone Loss

The international team of scientists identified hundreds of previously unknown genes that govern bone health and revealed cells surrounding blood vessels as one of the drivers of b...

Read source
orthotw.com /1 month ago

Bone's Hidden Battery: Future of Fracture Healing?

A fracture appears almost lifeless on postoperative radiographs. Weeks later, almost imperceptibly, biology awakens.

Read source
bioengineer.org /1 month ago

Sulfated polysaccharides target RANK Lys97 to inhibit osteoclast differentiation and reverse osteoporosis

Current osteoporosis treatments fail to balance bone resorption and formation. Here we show that engineered 2-N,6-O-sulfated chitosan (26SCS), a synthetic pentasaccharide, restores...

Read source
healio.com /1 month ago

Orthobiologics registry needs vertifiable data

Few areas of orthopedic practice have grown faster and with thinner evidence than orthobiologics. Platelet-rich plasma has moved from the periphery of sports medicine to our office...

Read source
healio.com /1 month ago

Orthobiologics registry needs vertifiable data

Few areas of orthopedic practice have grown faster and with thinner evidence than orthobiologics. Platelet-rich plasma has moved from the periphery of sports medicine to our office...

Read source
sciencedaily.com /11 hours ago

Scientists find a bone-building switch that could fight osteoporosis

An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same...

Read source
orthotw.com /1 month ago

Vivex Biologics Launches VIA Linxâ„¢, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advan...

New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies.

Read source
rna-seqblog.com /1 month ago

Genetic mapping identifies new hope for bone diseases

Single-cell RNA sequencing identified previously unknown genes and cell types that regulate bone health, revealing new opportunities for therapies targeting osteoporosis and other...

Read source
orthospinenews.com /3 weeks ago

Sports Medicine Biologics Market Research Report 2026-2031: Demand for Faster Recovery and Reduced Downtime Drives Marke...

August 19, 2026 05:21 ET  | Source: Research and Markets Dublin, Aug. 19, 2026 (GLOBE NEWSWIRE) — The “Sports Medicine Biologics…

Read source
orthospinenews.com /1 month ago

CMS Finalizes Higher Payment for CERAMENT® G in the US

08-03-2026 – BONESUPPORT™, a leading company in orthobiologics for the management of bone injuries, today announces that the…

Read source
fightaging.org /1 week ago

Physical Activity Correlates with Reductions in TMAO, Inflammation, and Harmful Bone Remodeling

Osteoporosis results from the slow loss of bone mineral density that occurs with advancing age, eventually leaving bones dangerously weak and prone to fracture. Bone extracellular...

Read source
orthospinenews.com /1 month ago

VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio

NEW YORK, July 29, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spine”) today announced that the U.S. Food and…

Read source
bioengineer.org /1 month ago

Osteocyte Parvalbumin Drives Mechanotransduction to Reduce Osteoarthritis Progression

A new study published in Nature Communications (2026) spotlights an unexpected molecular player in the battle against osteoarthritis: osteocyte parvalbumin. Osteocytes, the bone’s...

Read source
orthospinenews.com /3 weeks ago

BioLab Holdings Adds FastSkin®Autologous Wound Care Technology to Tissue Restoration Portfolio

NEWS PROVIDED BY BioLab Holdings, Inc.  Aug 19, 2026, 13:02 ET PHOENIX, Aug. 19, 2026 /PRNewswire/ — As part of…

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bone Biologics

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

orthospinenews.com

Recent coverage from public sources
Public source

ryortho.com

Recent coverage from public sources
Public source

fightaging.org

Recent coverage from public sources
Public source

healio.com

Recent coverage from public sources
Public source